Carbon Monoxide in Healthcare Monitoring Balancing Potential and Challenges in Public Health Perspective: A Narrative Review.

Carbon monoxide (CO) has medicinal potential and harmful qualities. However, excessive exposure to CO can lead to severe organ failure. CO is exogenously and endogenously generated within the human body. Ongoing research aims to uncover the beneficial aspects of CO. It serves as a biomarker for inflammation and other serious illnesses. Preclinical trials exploring CO's application have indicated potential benefits in addressing conditions such as Ischemia, Tendonitis, Neuropathic pain, and even cancer therapy. Cardiovascular disease emerges as a particularly promising target for CO therapy due to its potent vasodilatory effects. While research into CO-based therapeutics has shown promise in experimental and preclinical settings, clinical translation and widespread adoption remain in the early stages. This review will illuminate the advantageous role of CO as a biomarker alongside the obstacles and challenges associated with its implementation.